House Amendment 722 to House Bill 3
116th Congress(2019-2020)
An amendment numbered 12 printed in Part B of House Report 116-334 to increase funding for clinical trials at NIH and ban the use of spread pricing by PBMs as it relates to Medicaid.
Agreed To
Agreed to in House on Dec 12, 2019
Origin Chamber
House
Type
Amendment
Amendment
A proposed change to a pending text (e.g., a bill, resolution, another amendment, or a treaty [or an associated resolution of ratification]).
Amendment Number
722
Congress
116
12/12/2019
House amendment agreed to: On agreeing to the Houlahan amendment (A012) Agreed to by voice vote.
12/12/2019
On agreeing to the Houlahan amendment (A012) Agreed to by voice vote.
12/12/2019
Amendment (A012) offered by Ms. Houlahan. (consideration: CR H10217-10219; text: CR H10217-10218)
12/12/2019
House amendment offered
Dec 12, 2019
Passed House
107
Sponsorship
Public Record
Record Updated
Feb 8, 2022 11:01:28 PM